Acinetobacter/stenotrophomonas  by unknown
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Results: 53 episodes (50 pts) of PAP were found. All episodes had Acinetobacter/stenotrophomonas 
a definite microbiological diagnosis (23 had a+blood culture, 30 had 
a sterile brushing with 1000 colonies of Pseudomonas, 8 had 
a t  transthoracic pulmonary aspirate and in 2 the Pseudonionas grew 
in pleural fluid). Mean age was 59.5 years (range 17-92), 41 were 
male, and 83% were nosocomial. Overall directly related iiiortality 
was 41'% (22/53) with 8/22 (36%) early mortality. With respect to 
predisposing factors, 51 % of pi:s were on mechanical ventilation, 47% 
had hypoalbunimeiiiia, 79% had received previous antibiotic tx.. 
Neither any of the predisposing factors, the iiosocomial or coinmu- 
1p10481 Lipopolysaccharides of Acinetobacter: 
structure, specificity, and significance 
K. Pantophlet', L. Brade', L. Dijkshoorn2 , 0. Holst', H. Urade'. 
'Divis ion qf Medical and Biochemical Microbi~ilqqy, Research Center 
Borstel, Borstcl, Germany;  'Department  of Medical Micmbioiupy, Leidcw 
University Medical Cerzrec Lciden, The Netlierlartds 
nity origin of PA€! the presence of bactereniia, respiratory failure, 
metabolic acidosis or x-ray findi~igs had an influence 011 mortality. 
Pt\ who received an adequate empirical antibiotic (atb) tx (38/53, 
72%) had a lower early mortality, but no differences were found in 
the overdl mortality. There were no statistically significant differences 
between tx with a single antipseiidonional beta-lactamic atb (23 
cases) or with its association with an aminoglycoside (16 cases). The 
development of antimicrobial resistance during tx (based on sputum 
culture) in 8/27 (30%) did not influence the mortality. Conclusions: 
111 spite of a better supportive and atb tx of the 90's. it does not seem 
that the high iiiortality rate of PAP can be iniproved except for the 
use of adequate empirical dtb ,:overage. The outcome was similar in 
patients treated with a single beta-lactamic agent or the association 
with an aminoglycoside. 
(p10471 Ceftazidime 1 g t.i.d. versus 2 g t.i.d. (both 
with netilmicin) in the treatment of patients 
with nosocomial pneumonia 
G .  Hofien .  Kiinikum Benjaniiii Frankf in ,  B e d i n ,  Cerniaq  
Objetives: To evaluate the efficacy of ceftazidinie in either lg/tid 
(CAZI) or 2g/tid (CAZ2) dosage, each in combination with 
netilmicin (NET 400 mg/od) in intensive care patients with noso- 
coniial pneumonia. 
Methods: 103 patients (pi:s) with a confirmed clinical andlor 
bacteriological diagnosis of a riosocomial pneumonia were enrolled 
and received either CAZl (n=49) or CAZ2 (n=54) in combination 
with NET. Patients were clinically assessed and bacteriological spec- 
miens were evaluated on day 0, day 3 and within 1 day after end of 
treatment (up to day 20). 
Results: Clinical success (cure and improveiiient) was achieved in 
39 and 36 pts of the CAZI and CAZ2 group respectively, whereas 7 
and 9 ptc hiled to respond to the respective treatment. No signifi- 
cant differences could be den-ionstrated between both regiinen. A 
total of 12 pts could not be evduated due to death associated to the 
underlying diseases (CAZI : 2 pts and CAZ2: 5 pts) or other reasoiis 
(1 and 4 pts of CAZl  and CAZ2, recpectively). The most frequently 
isolated pathogens were Staphylococcus and Pseudomonas. At either 
dosage CAZ was equally well tolerated. The incidence of adverse 
events, niost of them unrelated to the antibiotic treatment, was simi- 
lar in both groups. 
Conclusions: It can be concluded that CAZ in combination with 
netilmicin can be successfully and safely adminstered in a Ig/tid 
dosage in the treatment of nosocomial pneumonia in intensive care 
patient?. 
Though generally considered not to be pathogenic, some species 
within the genus Acinetobacter have been found to be involved in 
nosocoiiiial infections with increasing frequency in recent years. To 
date, however, the phenotypic differentiation of most Arineiobarter 
species has been shown to be difficult, due to their close genetic and 
phenotypic relatedness. In fact, the unambiguous identification of 
many strains has been shown to be possible only by DNA-DNA 
hybridization, a time-consuming technique, which, hence, is not 
implenientable in diagnostic microbiology laboratories. In the last 
few years a variety of alternative molecular biology-based methods 
have been proposed and evaluated for their potential to identify 
Acinetobacter strains to the species level, but most require too much 
standardization or are not sufficiently discriminative. Unlike earlier 
reports, recent studies from our group on the lipopolysaccharides 
(LPS) from several Arinciiibarter strains have shown that they possess 
an 0-antigen. This, opens the possibility for an 0-serotyping scheme 
for Acinetobacter, as it has been done successfully in the past for other 
gram-negative bacterial genera. For this purpose, the chemical struc- 
ture of the 0-antigen from difrerent Aiirietohacier strains has been 
determined. Based on this knowledge, polyclonal and monoclonal 
antibodies have been generated and evaluated for their potential use 
in a serotyping scheme. The results obtained so far show that an 0- 
serotyping scheme for Acinetobacter i.y indeed feasible and, thus, may 
provide a simple way for the rapid identification of t h r x  oppor- 
tunistic pathogens in clinical laboratorich. 
(p10491 Comparison of Phoenix and Vitek Automated 
Susceptibility Test Systems for performance 
with Acinetobacter baumannii complex and 
Pseudomonas aeruginosa isolates 
T. Wiles, J. Hejna, M. Votta, B. Rosenberger, D. Holliday. Becton 
Dirkinson Microbiology Systems, Sparks, MD, U S A  
Objectives: To comparatively evaluate the Phoenix (DD Micro- 
biology Systems, MD. USA) and Vitek Systenms (bioMerieux, 
Hazelwood, MQUSA) for determination of antimicrobial suscepti- 
bility with Acinetobacter bauinannii complex and Pseudomonas 
aeruginosa isolates. 
Methods: A total of 147 strains including 64 A. bauinannii 
coniplex, and 78 €? aeruginosa were used in this study. Antimicrobial 
susceptibility test results to Ainikacin (AN), C;ciitaiiiicin (GM), 
Tobramycin (NN), Ciprofloxacin (CIP), Piperacillin (PIP), 
Ceftazidime (CAZ), Imipenem (IPM), and Aztreonani (ATM) from 
both sy%cms were compared to the NCCLS recommended standard 
broth microdilution method. 
Results: The overall interpretive agrecment for all agents with the 
Phoenix system was 96.3%, with a range of 93% (ATM) to 993%) 
(AN) for individual agents. In comparison, the Vitek system had a n  
overall interpretive agreement of 75% with a range of 48'% (PIP) t o  
88% (IPM). The time to completion ofthe test with the Vitek syctem 
was on average 9.5 h, approximately 1.5 11 faster than the Phoenix 
system. However, the Phoenix system had sigificantly fewer very 
major errors compared to the Vitek system. The very major errors 
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observed with Vitek were primarily associated with ATM and CAZ. 
Conclusions: The Prototype Phoenix system compares favorably to 
the Vitek system, providing an acceptable alternative for susceptibil- 
ity testing for Pseudomonas aeruginosa and members of the 
Acinetohacter baumannii complex. 
[=I Analysis of the epidemic multiresistant 
strains of Acinetobacter baumannii from two 
hospitals in Poland 
E.M. Stefaniuk, K. Trzcinski, W. Hryniewicz. Sera G Vaccines 
Central Research Laboratory, Warsaw, Poland 
Acinetobacter bauniannii is a Gram-negative bacillus that is responsible 
for an increasing number of nosocomial infections. It is difficult to 
control A .  bautnannii outbreaks because usually they are caused by 
multiresistant strains. 
Objectives: The aim of this study was to reveal the eventual relat- 
edness amongst A .  baumannii isolates collected from patients hospi- 
talised in two different hospitals in north-western Poland-in 
Szczecin and Kolobrzeg. 
Methods: Altogether 24 A .  baumannii isolates were recovered 
between December 1994 and April 1995. Twenty-three isolates were 
collected from adults hospitalised at intensive care units (ICUs) and 
other wards in which invasive procedures have been used. A single 
strain was isolated from a child located at ICU. 
Results: Isolates were reidentified to the species level by the 
PCR-based approach; susceptibility testing has revealed that all strains 
were multidrug-resistant. All the isolates produced similar RAPD 
patterns with RAPD-4, ERIC1 and ERIC2 primers and the same 
combined RAPD patterns were present in both hospitals. 
Conclusions: Typing results have suggested the homogeneous 
structure of the studied population of A .  baumannii and this could 
have resulted from the pauents mansfer between the two hospitals. 
lm1 Comparison of Vitek System and reference 
agar dilution method (NCCLS) for 
susceptibility testing of Acinetobacter spp. 
E.M. Stefauiuk, T. Kaminska. Sera G Vaccines Central Research 
Laboratory, Warsaw, Poland 
Acinetobacter spp. belongs to most common nosocomial pathogens, 
mostly isolated at intensive cai-e units (ICUs) and surgical wards. 
Usually it causes respiratory tract, bloodstream and urinary tract 
infections. High prevalence of niultiresistant strains makes it neces- 
sary to test susceptibility of each Acinetobacter isolate to a wide range 
of antimicrobial agents. 
Objectives: In this study the usefulness of the automated Vitek 
System (bioMerieux, Inc.USA) for antimicrobial susceptibility test- 
ing of Acinetobacter spp. was evaluated. 
Methods: Eighty-six nosocomial isolates collected in different 
hospitds in Poland were tested with Vitek GNS-F2 and GNS-104 
cards, and compared to the reference agar dilution method (NCCLS). 
The susceptibility was tested against 8 antimicrobial agents. 
Results: Interpretations of MICs obtained by both approaches 
were the same in 89.5% of cases for ampicillin, 86.0Y~carbeniciilin, 
87.2Y~piperacillin. 80.2Y~ticarcillin,96.59'~imipenem, 8 6 . 0 Y r  
ofloxacin, 88.4%-gentamicin, and 83.79'~amikacin. Vitek System 
was also compared with ATB Expression System (bioMerieux) for 
species identification. Acinetobacter isolates were studied with GNI 
cards (Vitek) and 1D32GN tests (ATB). With Vitek System we could 
identify 97% of strains and all of these were identified as A .  calcoaceti- 
cus bio. anitratus, whereas ATB System identified all the isolates as A .  
baumannii. This means there are differences in Acinetobacter spp. 
nomenclature between the two systems. 
Conclusions: Vitek System has been found accurate in identifi- 
cation and antibiotic susceptibility testing of Acinetobacter spp. 
[I Multiresistant Acinetobacter baumannii 
colonization: comparative value of rectal, skin 
and upper respiratory tract cultures 
C. Sanchez-CarriUo, B. Padilla. J. Guinea, L. Martinez, €? Adin, 
M.D. Puente, E. Bouza. Hospital General Gregorio Mararion, Madrid, 
Spain 
Objectives: The objective of our study was to determine the com- 
parative values of rectal, skin and upper respiratory tract cultures for 
the detection of multiresistant Acinetobacter baumannii (MR-Ab) carri- 
ers during an outbreak occurred in the Post-Surgical Intensive Care 
Unit (PS-ICU) in our hospital and spread to other areas. 
Methods: From April to November 1998 surveillance cultures 
were performed on  all patients 48 h after their admission to the PS- 
ICU and weekly until discharge. 
Results: Out of 1,320 samples, 206 were positive (corresponding 
to 36 patients). Rates of detection of MR-Ab were 7796, 76% and 
53% for skin, rectal and upper respiratory tract samples respectively 
Combination of two body sites samples yielded rates of detection of 
93% for skin and rectal cultures, 90% for rectal and respiratory 
cultures and 88% for skin and respiratory cultures. 
Conclusions: The results of our study suggest that the perfor- 
mance of the combination of skin and rectal cultures is the best way 
to detect MR-Ab carriers in order to quickly apply harrier methods. 
-1 Nosocomial multiresistant acinetobacter 
meningitis: another ungrateful complication 
with a difficult treatment 
M. Salavert', J.R. Bret6n1, J.L. L6pez-Hontangas', J. Gudin', J. 
L6pez Aldegue?, M. Blanes3, M. Gohernado'. 'Service .f 
Microbiolog~ 'fntensive Care Unit, .'lnzctious Diseases Unir, Uniitersity 
Hospital La Fe, Valencia, Spain 
Objectives: Nosocomial infections caused by Acinetohacter spp. 
have been increasing in frequency over the past years, mostly as 
bacteremia and respiratory tract infections. Nosocomial meningitis 
due to multiresistant Acinetobacter (NMMA) is much less common, 
but it may he an important problem in neurosurgery and critical care 
wards. We analyse the risk factors, clinical features, microbiological 
data and the outcome of NMMA. 
Patients and methods: We performed a retrospective study to 
evaluate the episodes of NMMA during the last five years. All patients 
met the inclusion criteria. Identification of Acinetobacter was 
performed by standard procedures. Susceptibility to antimicrobial 
agents was determined according to NCCLS. 
Results: There were seventeen patients (fourteen men and three 
women) between 2 and 7lyears of age with NMMA during the 
period of study The underlying conditions were: head trauma in 4 
(24%), subarachnoid or intracerebral hemorrhage in 4 (24%), 
intracranial tumor in 3 (18%), congenital malformations in 2, tuber- 
culous meningoencephalitis in 2,  CSF fistula and cryptogenetic 
hidrocephalus with 1, respectively. All cases underwent neurosurgi- 
cal procedures (external ventriculostomy drainage in 8, ventriculo- 
peritoneal shunts in 1, craniotoniiey in 3 and others in 2)  before the 
episode of meningitn, except three. Fourteen strains were idmtifzed 
as multiresistant A. baumannii-calcoaceticus complex (7 resistant to 
imipenem and aminoglycosides). I n  six cases (35%) the meningitis 
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was polymicrobial. Eleven patient5 were cured (65%) and five died 
(29%). in four due to different reasons of NMMA. In one patient the 
infection persisted with continuous relapses. 
Conclusions: NMMA cmstitute an increasing threat for patients 
who receiving antimicrobial therapy in intensive care units and are 
bei~ig maintaned by various hi>-support systems. 
m1 Acinetobacter baumannii strains isolated 
from intensive care patients: biotypes, 
resistance phenotypes, plasmid profiles 
M. Fleischcr, M. Stankiewicz, 0. Konisiewicz. Deparfment of 
Mirrobiolo,qy Wroclniu University of Medicine, Poland 
Objectives: The aim of the study was to characterize 51 clinical 
isolates of Acinctobacter baumannii recovered from 42 patients 
hospitalized in the Intensive C x e  Unit (ICU) of University Hospital, 
and to determine the clinical usefulness of biotyping, antibiotic resis- 
tance patterns and plasmid profile analysis In epidemiological inves- 
tigations. 
Methods: The isolates (bronchial secretion (32), intravascular 
catheter ( ( I ) ,  blood (4), urine (5) and wound (1)) were identified by 
the ATB system bioMerieux, France). Susceptibility to 12 antinii- 
crobial agents was detcrniiued by the ATU system and disk ditEisioii 
method (NCCLS). Plaainid DNA of isolates was obtained by the 
chloroform-phenol lysis method. Statistical analysis was performed 
using the Statistica PL. Statsoft Inc., Statistica for Windows 
(computer program) 
Results: The hiotypes of A. baumannii defined 15 groups; by the 
use of cluster analysis 3 main clusters were identified. Identical 
biotype were detected in 13 isolates. A.bauniannii strains were clas- 
sified into 4 different antibiograni cluster: A, B, C, D comprised 11, 
18, 8 and 14 isolates respect:ively. The isolates in cluster A were 
multiresistance. Plasmids were detected in 67% (34 of 5 1) 
Acinetobacter strains; 27 isolates had more than one plasmid. The 
strains could be subgrouped by plasmid profile analysis into seven 
plasmid patterns; similar plasmid profiles were observed in 15 isolates. 
Conclusions: Acinctobacter bauniannii strains represent multiple 
biotypes, antibiotic resistance patterns and plasmid profiles. Plasmid 
analysiq combined with biotyping and analysis of antibiotic resistance 
phenotypes proved to be useful in epidemiological typing of clinical 
isolates. 
I PI055 I Changes in prevalence and resistance of 
Acinetobacter 15pp. in a neurologic intensive 
care unit 
S. Koljalg',2, I? Naaber'.', E. Sepp', M. Mikelsaarl. 'Laboratory ?I 
Microbioloyy, United Lnboratories, Clinicirm of flip University of Tartu, 
'Departnzcwt ?flfMierohiolqyy, University of Tartn, Tartu, Estonia 
Objectives: To investigate the dynamic prevalence of potential 
pathogens (PP) in clinical sa:mples of neurological intensive care 
patients and follow the changes in resistance patterns of their most 
frequent nosocomial pathogens. 
Methods: Data about isolated microbes from clinical samples in 
the years 1995 and 1997 in ~ieuorological ICU of Tartu. University 
Hospital. 
Results: Altogether 472 and 316 PPs were isolated respectively in 
1995 and 1997. The prevailing microbe waq iirinctobacter spp., making 
in  both years 31 .4 md 36.1'X. respectively from isolated PPs. 
Aiirlctilhoct',rspp. w ~ s  the most c ominon PP in rcspiratory tract, blood, 
cerebrospinal liquid, and wound exsudate samples in both years and 
in urine samples in 1997. There was statistically significant (piO.05) 
increase in prevalence of Stapi~yiocorrus a r r r e ~ ~ s  aiid Kiebsieila spp. and 
decrease in Pseudumonas spp. between the years. In 1995, as compared 
to 1997, the Acinetobacter spp. were more sensitive (p<0.05) to 
gentamicin (35.6 vs. 11.3%), cefiazidinie (61.9 vs. 46.6%) and 
ainikacin (97.7 vs. 67.1%). In 1997, niost of the Aciwetobacfcr spp. 
isolates were sensitive to iniipeneni (98.6%) and meropeneni (90.6%). 
However, the sensitivity to ampicillin, piperacilliii, cefotaxinie, and 
aztreonani was low (8517.5%) 
Conclusions: I n  our study, Acinctobacter spp. was the most 
common nosoconiial pathogen in ICU in 1995 and l(997. There was 
an increase in S. aweus and Klebsiella spp. and decrease of P.~eirdonionas 
spp. derived infections. The increasing resistance of Acinetobactcr spp. 
may be associated with increasing use of 111 generation cephalosporms 
and amikacin. 
Ip10561 Acinetobacter species in hospitalized patients 
L. LXjkshoorn', B. van Harsselaar', W. van Leeuwen'. W. Hop'. 
'Lpiden Univcvsify Hospital Medical Centeu, Leiden, 'Erasmrrs (hiversi fy ,  
Rotterdam, T h e  Netherlands 
Objectives: To assess the prevalence of Acinetobacrcr (grnomic) 
species in hospitalized patients 
Methods: Four patient groups In a university hospital were inves- 
tigated for the presence of Acinetobaeter on skin and niucosae. Group 
1-111 contained patients admitted to the intensive care units (ICUs) 
and had no history of Acinetobacter . Group 1 patients (n=38) had a 
stay of 3 days or less, whereas the duration of admittance of patients 
in group 11 (n=31) and 111 (n=48) was 14 days or more. Patients in 
group 111 (n=48) used antibiotics, but those in group 1 aiid I1 (11=31) 
did not. Patients of group IV (n=33) were admitted to different 
departments and were included on the basis of the noted presence of 
Acirretobarter in specimens taken from them for clinical reasons. Swabs 
were taken from 10 sites of skin and niucosae. Samples were grown 
by enrichment cultivation. 
Results: The number of patients with glucose acidifying acineto- 
bacters in groups I- I11 were respectively 3, 3 aiid 9 with no signifi- 
cant difference between these 3 groups. Group IV, differed from the 
other groups in that 15/33 patients had glucose acidifying 
Acinetobacter in one or more skin or niucosal site (p<O.OS). A .  
banmantrii and genomic species 3 were the most prevalent species in 
these patients. 
Conclusions: Patients with A.  bauniannii and genoiiiic species 3 
in their clinical specimens frequently carried these organisms also on 
skin and niucosae. These findings suggest that the colonized patient 
can be the source from which spread occurs. 
[p10571 Epidemiology and characterization of 
Acinetobacter baumannii strains 
R. Watschinger, A. WeiB, H. Hutter, G. Fluch, J. Schallauer, C 
Jebelean, M. Haditsch, L. Binder, H. Mitternmayer. Elisabcfliinctz 
Hospital, L i n z ,  Airstria 
Acinetobacter baumannii is an important cause of nosocomial infec- 
tion, especially in patients in intensive care units and outbreak5 cmced 
by multiresistant strains of this pathogen have been reported widely. 
During a period from 1993 to 1998, 99 strains from clinical inater- 
ial and froin surveillance cultures were collected. The sources of the 
isolates were as follows: blood n=S, respiratory specimens n=53, 
gastrointestiixil upeciuiens n= 16, urine n=7, and other specimens 
n=16. Repeat isolates from the 5aiiie patient and material were 
excluded. 
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Methods: The identification of strains was done by the Api 20 
NE System according to the manufacturer’s instructions. 8 antibiotics 
were tested by the disc diffusion method according to NCCLS stan- 
dards to obtain an antibiotic profile. Antibiotics tested included 
ampicillin, cefazolin, gentamicin, tetracyclin, chloramphenicol, sul- 
fonamides, norfloxacin, cefotaxim and imipenem. O n  all strains an 
arbitrarily primed PCR was done using the primer DAF 4. 
Results and conclusions: By the API 20 NE 12 different 
biotypes were identified. The API-profile 0001073 domnated 
(61%1), followed by the profile 0041073 (16%). Genomic analysis 
showed the presence of 8 different genotypes. 90% of all strains could 
be grouped in 8 different genotypes. The most predominant 
Genotype was type B (34%), followed by type A (14%) and type C 
and D (12% each). The percentage of the different genotypes 
changed over the observation period. Out of 8 different resistance 
patterns the dominating one (87%) comprised all 8 genotypes . 
m1 Antibiotic susceptibility testing of 
Stenotrophomonas maltophilia with 
trimethoprim/sulfamethoxazole using the 
Phoenix System 
C. Yu, D. Turner, B. Turng, H. Lilli, J. Hong. Becton Dickinsoa 
Microbiology Systems, Sparks, MD, USA 
Objectives: To evaluate a new automated antibiotic susceptibility 
test system, Phoenix, for the determination of MICs when testing 
Stenotrophomonas maltophilia (SM) with trimethoprim/ 
sulfaniethoxazole (SXT). 
Methods: A newly developed rapid AST system, Phoenix, was 
evaluated for testing the susceptibility of SM with SXT. The PASCO 
System (BD Microbiology Systems) was used as a reference method 
A total of 97 strains of SM and 4 NCCLS recommended QC strains 
were tested with the Phoenix and PASCO in parallel using a single 
inoculum preparation. Discrepant results between the two systems 
were resolved by the agar dilution method (AD), performed per 
NCCLS procedures. A total of 31 isolates (27 SM and 4 QC ) were 
tested twice independently to evaluate reproducibility. 
Results: For the 97 strains tested, the EA between the two systems 
was 96% with no very major errors. There were 2 strains which tested 
resistant (MIC - 4_g/ml) by Phoenix but susceptible by PASCO 
(confirmed by AD) resulting in 2.3% major errors. The time to result 
of the Phoenix system for SM /SXT Combination was 7-12 h. 
Reproducibility of the system was 90%. 
Conclusions: These data suggest the feasibility of testing suscep- 
tibility of SM with SXT in the Phoenix system. We believe that 
further enhancements to performance and reproducibility could be 
achieved through a more comprehensive and diverse database. 
/p10591 Cefepime and 6-lactamase inhibitor 
combinations against clinical isolates of 
Stenotrophomonas maltophilia 
R. C a n t h ,  S. Valdezate, B. Sanchez del Saz, M. Pkrez-Vazquez, A. 
Oliver, E. Loza, E Baquero. Microbiologia, Hospital Ram& y Cajal, 
Madrid, Spain 
Objectives: To explore the synergistic effect of R-lactanis, particu- 
larly cefepime, (FEP) with R-lactamase inhibitors in S. ~ d o p h i l i a  
clinical isolates. 
Methods and results: The synergy of FEP, aztreonam (ATM) 
and ceftazidime (CAZ) in the double disk-diffusion test (DDS) with 
co-amoxiclav was determined in 114 S. maltophilia isolates: 41% 
isolates accounted for a DDS-positive test for FEP, 29% for ATM, 
and 9.6% for CAZ. Thirty-two strains with different MICs for CAZ, 
16 DDS-positive for FEE! were selected to determine the activity of 
&lactanis, alone or in combination with clavulanate (CLV), tazobac- 
tam (TZB), and sulbactam (SLB) by agar dilution method. MICs 
(pg/ml) are summarized: 
.. .. 
ATM 32-1024 256 1024 128-21024 21024 21024 
2pg/mlCLV 4-1024 16 32 4-21024 21024 21024 
CAZ 1-256 32 64 4-512 128 512 
2pg/mlCLV 1-128 16 64 4-512 128 512 
4pgImlCLV 0.5-256 8 64 4-512 128 512 
FEP 8-128 32 64 16-256 64 128 
2pg/mlCLV 1-64 8 32 8-128 64 128 
4pgImlCLV 1 - 6 4  8 32 8-128 64 128 
4pgImlTZB 4 - 3 2  8 16 4-128 32 128 
8pgImlSLB 4 - 3 2  16 32 4-128 32 64 
Conclusions: DDS-positive results were more frequently with FEP 
Its activity, alone or in combination with R-lactamase inhibitors, was 
higher to that of ATM or CAZ. DDS with FEP could be useful to 
separate phenotypes in S. maltophdia. 
(p10601 Comparative studies of antibiotic 
susceptibility of Stenotrophomonas 
maltophilia with 
trimethoprim/sulfamethoxazole using 
different test methodologies 
T. Wiles, B. Turng, V. Towns, H. Lilli, S. Wulff. Becton Dickinson 
Microbiology System, Sparks, MD, USA 
Objectives: To compare performance of different AST methodolo- 
gies in determining susceptibility of Stenotrophomonas maltophilia 
(SM) with trimethoprim/sulfamethoxazole (SXT). 
Methods: Standard Broth Micro-dilution (SBM), a dried-down 
form of broth microdilution (DMD), Etest (AB Biodisk, 
Sweden)(ET). agar disk ditfusion (DD) and agar dilution (AD) meth- 
ods were used to test the susceptibility of SM with SXT. A total of 
97 strains of SM and 4 Q C  strains were included in the study. A single 
inoculum was prepared and adjusted to a McFarland 0.5 standard in 
saline. Each test result was interpreted by at least 2 trained technol- 
ogists after 18 and 24 h of incubation at 35°C in ambient air. 
Results: Readings taken at 18 or 24 h did not show a difference 
in MICs with SBM or DMD; however, the 24 h reading improved 
the visual interpretation with ET, DD or AD for strains showing hazy 
zones/growth. The essential accord between any two methods 
ranged from 80-95%. Discrepancies tended to occur around the 
break-point. Further statistical analyses revealed ET and AD were 
significantly correlated, as well as DMD and DD. 
Conclusions: Due to the methodological differences associated 
with each AST procedure which is further complicated by trailing 
endpoints with SXT, we recommend that for strains with MICs 
around the break-point or higher, confirmation by a different 
method may provide more reliable results. 
Ip10611 S. maltophilia isolated in Bloemfontein, SA 
M. Reyneke, L. Chalkley University of fhe Orange-Free State, 
Bloemfontein, South Africa 
Objectives: Stenotrophomonas maltophilia is an opportunistic 
pathogen of increasing importance in the immuno-compromised 
host. This study was designed to investigate in vitro efficacy of antibi- 
otics, and to establish a strain typing system. 
Methods: Clinical isolates of S. maltophilias (75 strains) were 
obtained from Bloemfontein Academic hospitals over the period 
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8/10/1997-28/04/1998. The isolates were identified by the API 
20NE system. MICs were determined by the agar dilution method 
employing NCCLS methods. Trimethoprim-sulphaniethoxazole 
(TMP/SMX) MICs were coriipaired/comfirmed using E tests. Kill 
curves were performed basicallly as described for bacteriocidal activ- 
ity according to NCCLS. Randomly amplified polymorphic DNA 
Ip10631 PCR-based detection of Burkholderia 
pseudomallei in paraffin-embedded tissues 
R.M. Hagen, H. Neubauer, G. Zysk, E.-J. Ftnkr, Y. Gauthicr, 
D. Vidal. Znstittrte of Mirrobiolopy, FAF hfcdital Amdemy, ;Wmir/ i ,  
Germarzy 
(RAPD) profiles were generated by two independant primers. 
Results: O f  the 75 S. maltophilia strains 45 were isolated from 
respiratory samples and 4 from blood. Percentage resistance to the 
antibiotics investigated was: piperacillin, 69%); piperacillin-tazobac- 
tam, 63%; ceftazidinie, 71%; irnipenem, 100%; aniikacin, 97%; tetra- 
cycline, 64%); TMP/SMX, 3%~; ciprofloxacin, 27% and trovafloxacin, 
1%. By means of kill-curves it was established that ciprofloxacin in 
combination with TMP/SMX produced an indifferent effect. RAPD 
profiling was performed on 213 strains from 11 patients. No cross- 
infection was evident. O f  seven patients from which more than one 
isolate was investigated four patients were seen to be infected with 
more than one strain type. 
Conclusions: The majority of South-African isolates of S. 
maltophilia remain susceptible to TMP/SMX. Trovafloxacin 
performed exceptionally well, being 2-4 fold more effective than 
ciprofloxacin. Fingerprinting of multiple strains from individual 
patients revealed co-infection with diverse strain types. The findings 
of specific case studies will be elucidated. 
[=I Comparison of'the bacteremia caused by 
Stenotrophomonas maltophilia among 
patients with and without onco-hematologic 
malignancies 
M. Salavert Lleti', P. Ubeda', J.L. L6pez-Hontangas1, J. L6pez- 
Aldeguer', I .  Jarque", C. P&e:r-Bell&s', M. Gobernado'. 
Departnrriifs of 'Mirvohioioxy, 'li?terrm/ Medirinr and 'He;nafohgy, 
Hospital La Fe, Valenria, Spain 
Objectives: To determine the clinic and epidemiological character- 
istics of the hacteremia for Stenotrophomonas maltophilia (BSM) in 
oncohaematological patients as  compared to other groups, and to 
study the antimicrobial susceptibility of the strains isolated. 
Patients and methods: During a period of 6 years (1990-1996) 
we reviewed the evolution, epidemiology, clinical and microbiolog- 
ical data of the patients with ElSM in a university hospital. 
Results and conclusions: We identified 27 episodes of BSM in 
26 patients. Half of them were women and age (meankSD) was of 
40k21 years. Twelve patients had oncohaematological malignancies 
(48%) and the most frequent diagnostic was acute myeloid leukemia 
(5 patients). The others fourteen were suffering a variety of under- 
lying diseases (connective tissue disorders, chronic airways obstruc- 
tion, burn wound infection, multiple trauma and HIV infection). 
BSM risk factors were previous broad spectrum antibiotic use 
(21/26), and central venous line (19/26) in both groups (81% and 
7394, respectively). There were no significant differences in age, 
origin of infection, nature of bacterenlia (monomicrobial or polymi- 
crohial, community or hospital acquired), presence of septic shock, 
mortality or outcome between the two groups, but the neutropenia 
and miniunosupresive treatment were more frequent in the onco- 
haematological group. The antimicrobial susceptibility of the 26 
strains was: triniethoprim-sulfamethosazole 90% of isolates, ticar- 
cilin/clavulanic 67%), ciprofloxacin 6096, and imipeneni 18% only. In 
our experience, triniethopriiii-sulfamethosazole remains the treat- 
ment of choice in Stenotrophomonas maltophilia infections. 
Objectives: Burkholderia pseudomallei is the causative agent of 
melioidosis, a glanders-like disease of tropical areas particularly South 
East Asia. Beside classical microbiological investigations efforts have 
been made based on molecular methods. There is a high risk of infec- 
tion for laboratory personnel due to the infectivity of B. pseudoma- 
llei. The PCR-amplification of Burkholderia spp. in tissues after 
formalin-fixation and paraffin-embedding has not been described yet. 
Methods: The method of DNA isolation and PCR ainplification 
was applied on sections of routinely formalin-fixed and paraffin- 
embedded tissues from infected mice. Oligonucleotide primer5 to 
amplify a DNA fragment coding for the rpsu21 gene of the bacteria 
were used. 
Results: After dewaxing of tissue sections DNA was successfully 
isolated and amplified from 5 of 6 samples. After optiinising the 
protocol we found that headcold treatments of samples did not 
improve the amount of obtained DNA. 
Conclusions: The ability to amplify bacterial DNA from forma- 
lin-fixed, paraffin-embedded tissues allows analysis of archival tissues 
or biopsy material for the diagnosis ofinfections caused by B. pseudo- 
mallei. In comparison with conventional methods the procedure 
allows a rapid identification at reduced risk of infection for labora- 
tory personnel. 
Bacterernia/endocarditis 
1 PI 064 I Bacteremia complicating pressure ulcers 
E. Espejo, A. Key, E. Garcia-Restoy, E. Anoro, M.A. Morera, I? 
Bella. Hospital dc Zrrassa, Errarsa, Spain 
Objectives: To evaluate the clinical and microbiological character- 
istics of bacteremia complicating pressure ulcers (BCPU). 
Methods: Prospective study of episodes of significant BCI'U. 
Diagnosis was based on positive blood cultures, results of ulcer culture 
and absence of another source of the bacteremia. 
Results: We studied 33 consecutive episodes of BCPU in 30 
patients (13 males, 17 females) aged 77213 yr. The causative agents 
were: P mirahilis (1 1 cases), S. nureus (9), Barteroides sp. (7), E. coli (4), 
P aemginosa (3), and several aerobic (6) and anaerobic (2) grain-posi- 
tive cocci. Bactereniia was polimicrobial in 8 cases (24%). We did not 
identify data permitting a reliable prediction of the etiologic agent. 
Dementia, stroke and femur fracture were the most coninion under- 
lying conditions. The ulcers were already present at admission in 27 
cases, but the bacteremia was hospital-acquired in 16 case3. Multiple 
ulcers were present in 25 cases. The sacrum wa5 the most common 
site (24 cases) followed by heels (11) and trochanteric region (8). I n  
5 cases, ulcers did no show distinct local signs of infection; in 4 of 
these cases, S. auretrs was isolated from blood and ulccr cultures. 
Surgical debridenient was required in 22 cases. Osteoniyelitis was 
documented in 5 cases. Crude mortality was 42'% and mortality 
related to bacteremia was 15%. 
Conclusions: BCI'U is associated with a high mortality, although 
many deaths were not directly related to hacteremia. I'oliniicrobial 
bacterenna is common. Empirical therapy should be active against 
enteric gram-negative bacilli, S. aurerrs, l? aemginosa, and anaerobes 
including B. fragilis. 
